wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q38816700-2894A475-B228-4111-AF3A-406D429DFEEC
Q38816700-2894A475-B228-4111-AF3A-406D429DFEEC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38816700-2894A475-B228-4111-AF3A-406D429DFEEC
Current and developing therapies for the treatment of non-small cell lung cancer with ALK abnormalities: update and perspectives for clinical practice.
P2860
Q38816700-2894A475-B228-4111-AF3A-406D429DFEEC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38816700-2894A475-B228-4111-AF3A-406D429DFEEC
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
8ed99a262419342e9138bf74a027db356440a035
P2860
PF-06463922, an ALK/ROS1 Inhibitor, Overcomes Resistance to First and Second Generation ALK Inhibitors in Preclinical Models